Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Hayashi

Showing results (291-300 of 324) with videos related to

Pageof 33
Sort By:
Breast Cancer (Tokyo, Japan)|December 22, 2022
Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 2018Keiichiro Tada, Hiraku Kumamaru, Hiroaki Miyata, et al.
Breast Cancer Research and Treatment|September 21, 2016
Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer RegistryAkemi Kataoka, Takayuki Iwamoto, Eriko Tokunaga, et al.
Breast Cancer Research and Treatment|August 28, 2019
A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database studyMakoto Kubo, Masaaki Kawai, Hiraku Kumamaru, et al.
Plos One|November 9, 2016
miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver MetastasisTomohiro Iguchi, Sho Nambara, Takaaki Masuda, et al.
Breast Cancer Research and Treatment|April 7, 2016
Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer RegistryTakayuki Iwamoto, Hiraku Kumamaru, Hiroaki Miyata, et al.
Cancer|May 4, 2018
Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysisAntonios Valachis, Eleftherios P Mamounas, Elizabeth A Mittendorf, et al.
BMC Cancer|January 8, 2021
Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BCKatsuhiko Nakatsukasa, Naoki Niikura, Kosuke Kashiwabara, et al.
Oncology|June 18, 2018
Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell CarcinomaTomohiro Iguchi, Masami Ueda, Takaaki Masuda, et al.
Breast Cancer (Tokyo, Japan)|May 13, 2020
Annual report of the Japanese Breast Cancer Society registry for 2016Makoto Kubo, Hiraku Kumamaru, Urara Isozumi, et al.
Annals of Translational Medicine|May 14, 2021
Oral care and oral assessment guide in breast cancer patients receiving everolimus and exemestane: subanalysis of a randomized controlled trial (Oral Care-BC)Masahiro Umeda, Yoshihide Ota, Kosuke Kashiwabara, et al.
Pageof 33

Showing results (291-300 of 324) with videos related to

Sort By:
Pageof 33
Breast Cancer (Tokyo, Japan)|December 22, 2022
Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 2018Keiichiro Tada, Hiraku Kumamaru, Hiroaki Miyata, et al.
Breast Cancer Research and Treatment|September 21, 2016
Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer RegistryAkemi Kataoka, Takayuki Iwamoto, Eriko Tokunaga, et al.
Breast Cancer Research and Treatment|August 28, 2019
A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database studyMakoto Kubo, Masaaki Kawai, Hiraku Kumamaru, et al.
Plos One|November 9, 2016
miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver MetastasisTomohiro Iguchi, Sho Nambara, Takaaki Masuda, et al.
Breast Cancer Research and Treatment|April 7, 2016
Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer RegistryTakayuki Iwamoto, Hiraku Kumamaru, Hiroaki Miyata, et al.
Cancer|May 4, 2018
Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysisAntonios Valachis, Eleftherios P Mamounas, Elizabeth A Mittendorf, et al.
BMC Cancer|January 8, 2021
Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BCKatsuhiko Nakatsukasa, Naoki Niikura, Kosuke Kashiwabara, et al.
Oncology|June 18, 2018
Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell CarcinomaTomohiro Iguchi, Masami Ueda, Takaaki Masuda, et al.
Breast Cancer (Tokyo, Japan)|May 13, 2020
Annual report of the Japanese Breast Cancer Society registry for 2016Makoto Kubo, Hiraku Kumamaru, Urara Isozumi, et al.
Annals of Translational Medicine|May 14, 2021
Oral care and oral assessment guide in breast cancer patients receiving everolimus and exemestane: subanalysis of a randomized controlled trial (Oral Care-BC)Masahiro Umeda, Yoshihide Ota, Kosuke Kashiwabara, et al.
Pageof 33